Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve cost, efficiency, and outcomes of surgical procedures, today announced that management will participate in the Canaccord Genuity 41^st Annual Growth Conference, which will be held virtually from August 10th-12th. Management is scheduled to present on Thursday, August 12th at 9:00 a.m. Eastern Time and will participate in virtual investor meetings throughout the day.

A live audio webcast of the presentation will be accessible to the public on the Company's website at https://www.vicarioussurgical.com/. An archive of the webcast will be available for replay following the conference.

About Vicarious Surgical

Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of improving patient outcomes, increasing the efficiency of surgical procedures, and reducing healthcare costs. The Company’s novel surgical approach uses a combination of proprietary human-like surgical robots and immersive reality to transport surgeons inside the patient to perform minimally invasive surgery. The Company’s technology was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA), making it the first, and only, surgical robot to receive this designation from the FDA.¹ The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Eric Schmidt's Innovation Endeavors, Jerry Yang's AME Cloud Ventures, and Philip Liang’s E15 VC. The Company is now headquartered in Waltham, MA.

¹ As of the date of this press release, Vicarious Surgical is not aware of any surgical robotics company that has announced receiving Breakthrough Designation for a full robotics system.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210809005413/en/